Cervical and colorectal cancer screening prevalence before and after Affordable Care Act Medicaid expansion

Nathalie Huguet, Heather Angier, Rebecca Rdesinski, Megan Hoopes, Miguel Marino, Heather Holderness, Jennifer Devoe

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Community health centers (CHCs), which serve socioeconomically disadvantaged patients, experienced an increase in insured visits after the 2014 Affordable Care Act (ACA)coverage options began. Yet, little is known about how cancer screening rates changed post-ACA. Therefore, this study assessed changes in the prevalence of cervical and colorectal cancer screening from pre- to post-ACA in expansion and non-expansion states among patients seen in CHCs. Electronic health record data on 624,601 non-pregnant patients aged 21–64 eligible for cervical or colorectal cancer screening between 1/1/2012 and 12/31/2015 from 203 CHCs were analyzed. We assessed changes in prevalence and screening likelihood among patients, by insurance type and race/ethnicity and compared Medicaid expansion and non-expansion states using difference-in-difference methodology. Female patients had 19% increased odds of receiving cervical cancer screening post- relative to pre-ACA in expansion states [adjusted odds ratio (aOR)= 1.19, 95% confidence interval (CI)= 1.09–1.31]and 23% increased odds in non-expansion states (aOR = 1.23, 95% CI = 1.05–1.46): the greatest increase was among uninsured patients in expansion states (aOR = 1.36, 95% CI = 1.16–1.59)and privately-insured patients in non-expansion states (aOR = 1.43, 95% CI = 1.11–1.84). Colorectal cancer screening prevalence increased from 11% to 18% pre- to post-ACA in expansion states and from 13% to 21% in non-expansion states. For most outcomes, the observed changes were not significantly different between expansion and non-expansion states. Despite increased prevalences of cervical and colorectal cancer screening in both expansion and non-expansion states across all race/ethnicity groups, rates remained suboptimal for this population of socioeconomically disadvantaged patients.

Original languageEnglish (US)
Pages (from-to)91-97
Number of pages7
JournalPreventive medicine
Volume124
DOIs
StatePublished - Jul 1 2019

Fingerprint

Patient Protection and Affordable Care Act
Medicaid
Early Detection of Cancer
Uterine Cervical Neoplasms
Colorectal Neoplasms
Community Health Centers
Odds Ratio
Confidence Intervals
Vulnerable Populations
Electronic Health Records
Insurance

Keywords

  • Affordable Care Act
  • Cancer screening
  • Medicaid
  • Primary healthcare
  • Socioeconomic status

ASJC Scopus subject areas

  • Epidemiology
  • Public Health, Environmental and Occupational Health

Cite this

Cervical and colorectal cancer screening prevalence before and after Affordable Care Act Medicaid expansion. / Huguet, Nathalie; Angier, Heather; Rdesinski, Rebecca; Hoopes, Megan; Marino, Miguel; Holderness, Heather; Devoe, Jennifer.

In: Preventive medicine, Vol. 124, 01.07.2019, p. 91-97.

Research output: Contribution to journalArticle

Huguet, Nathalie ; Angier, Heather ; Rdesinski, Rebecca ; Hoopes, Megan ; Marino, Miguel ; Holderness, Heather ; Devoe, Jennifer. / Cervical and colorectal cancer screening prevalence before and after Affordable Care Act Medicaid expansion. In: Preventive medicine. 2019 ; Vol. 124. pp. 91-97.
@article{57f26275a09240a8aff19b993050886c,
title = "Cervical and colorectal cancer screening prevalence before and after Affordable Care Act Medicaid expansion",
abstract = "Community health centers (CHCs), which serve socioeconomically disadvantaged patients, experienced an increase in insured visits after the 2014 Affordable Care Act (ACA)coverage options began. Yet, little is known about how cancer screening rates changed post-ACA. Therefore, this study assessed changes in the prevalence of cervical and colorectal cancer screening from pre- to post-ACA in expansion and non-expansion states among patients seen in CHCs. Electronic health record data on 624,601 non-pregnant patients aged 21–64 eligible for cervical or colorectal cancer screening between 1/1/2012 and 12/31/2015 from 203 CHCs were analyzed. We assessed changes in prevalence and screening likelihood among patients, by insurance type and race/ethnicity and compared Medicaid expansion and non-expansion states using difference-in-difference methodology. Female patients had 19{\%} increased odds of receiving cervical cancer screening post- relative to pre-ACA in expansion states [adjusted odds ratio (aOR)= 1.19, 95{\%} confidence interval (CI)= 1.09–1.31]and 23{\%} increased odds in non-expansion states (aOR = 1.23, 95{\%} CI = 1.05–1.46): the greatest increase was among uninsured patients in expansion states (aOR = 1.36, 95{\%} CI = 1.16–1.59)and privately-insured patients in non-expansion states (aOR = 1.43, 95{\%} CI = 1.11–1.84). Colorectal cancer screening prevalence increased from 11{\%} to 18{\%} pre- to post-ACA in expansion states and from 13{\%} to 21{\%} in non-expansion states. For most outcomes, the observed changes were not significantly different between expansion and non-expansion states. Despite increased prevalences of cervical and colorectal cancer screening in both expansion and non-expansion states across all race/ethnicity groups, rates remained suboptimal for this population of socioeconomically disadvantaged patients.",
keywords = "Affordable Care Act, Cancer screening, Medicaid, Primary healthcare, Socioeconomic status",
author = "Nathalie Huguet and Heather Angier and Rebecca Rdesinski and Megan Hoopes and Miguel Marino and Heather Holderness and Jennifer Devoe",
year = "2019",
month = "7",
day = "1",
doi = "10.1016/j.ypmed.2019.05.003",
language = "English (US)",
volume = "124",
pages = "91--97",
journal = "Preventive Medicine",
issn = "0091-7435",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Cervical and colorectal cancer screening prevalence before and after Affordable Care Act Medicaid expansion

AU - Huguet, Nathalie

AU - Angier, Heather

AU - Rdesinski, Rebecca

AU - Hoopes, Megan

AU - Marino, Miguel

AU - Holderness, Heather

AU - Devoe, Jennifer

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Community health centers (CHCs), which serve socioeconomically disadvantaged patients, experienced an increase in insured visits after the 2014 Affordable Care Act (ACA)coverage options began. Yet, little is known about how cancer screening rates changed post-ACA. Therefore, this study assessed changes in the prevalence of cervical and colorectal cancer screening from pre- to post-ACA in expansion and non-expansion states among patients seen in CHCs. Electronic health record data on 624,601 non-pregnant patients aged 21–64 eligible for cervical or colorectal cancer screening between 1/1/2012 and 12/31/2015 from 203 CHCs were analyzed. We assessed changes in prevalence and screening likelihood among patients, by insurance type and race/ethnicity and compared Medicaid expansion and non-expansion states using difference-in-difference methodology. Female patients had 19% increased odds of receiving cervical cancer screening post- relative to pre-ACA in expansion states [adjusted odds ratio (aOR)= 1.19, 95% confidence interval (CI)= 1.09–1.31]and 23% increased odds in non-expansion states (aOR = 1.23, 95% CI = 1.05–1.46): the greatest increase was among uninsured patients in expansion states (aOR = 1.36, 95% CI = 1.16–1.59)and privately-insured patients in non-expansion states (aOR = 1.43, 95% CI = 1.11–1.84). Colorectal cancer screening prevalence increased from 11% to 18% pre- to post-ACA in expansion states and from 13% to 21% in non-expansion states. For most outcomes, the observed changes were not significantly different between expansion and non-expansion states. Despite increased prevalences of cervical and colorectal cancer screening in both expansion and non-expansion states across all race/ethnicity groups, rates remained suboptimal for this population of socioeconomically disadvantaged patients.

AB - Community health centers (CHCs), which serve socioeconomically disadvantaged patients, experienced an increase in insured visits after the 2014 Affordable Care Act (ACA)coverage options began. Yet, little is known about how cancer screening rates changed post-ACA. Therefore, this study assessed changes in the prevalence of cervical and colorectal cancer screening from pre- to post-ACA in expansion and non-expansion states among patients seen in CHCs. Electronic health record data on 624,601 non-pregnant patients aged 21–64 eligible for cervical or colorectal cancer screening between 1/1/2012 and 12/31/2015 from 203 CHCs were analyzed. We assessed changes in prevalence and screening likelihood among patients, by insurance type and race/ethnicity and compared Medicaid expansion and non-expansion states using difference-in-difference methodology. Female patients had 19% increased odds of receiving cervical cancer screening post- relative to pre-ACA in expansion states [adjusted odds ratio (aOR)= 1.19, 95% confidence interval (CI)= 1.09–1.31]and 23% increased odds in non-expansion states (aOR = 1.23, 95% CI = 1.05–1.46): the greatest increase was among uninsured patients in expansion states (aOR = 1.36, 95% CI = 1.16–1.59)and privately-insured patients in non-expansion states (aOR = 1.43, 95% CI = 1.11–1.84). Colorectal cancer screening prevalence increased from 11% to 18% pre- to post-ACA in expansion states and from 13% to 21% in non-expansion states. For most outcomes, the observed changes were not significantly different between expansion and non-expansion states. Despite increased prevalences of cervical and colorectal cancer screening in both expansion and non-expansion states across all race/ethnicity groups, rates remained suboptimal for this population of socioeconomically disadvantaged patients.

KW - Affordable Care Act

KW - Cancer screening

KW - Medicaid

KW - Primary healthcare

KW - Socioeconomic status

UR - http://www.scopus.com/inward/record.url?scp=85065515444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065515444&partnerID=8YFLogxK

U2 - 10.1016/j.ypmed.2019.05.003

DO - 10.1016/j.ypmed.2019.05.003

M3 - Article

VL - 124

SP - 91

EP - 97

JO - Preventive Medicine

JF - Preventive Medicine

SN - 0091-7435

ER -